$331 Million is the total value of WILKINS INVESTMENT COUNSEL INC's 73 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MANH | Exit | Manhattan Associates | $0 | – | -5,200 | -100.0% | -0.07% | – |
| CI | Exit | Cigna | $0 | – | -1,928 | -100.0% | -0.12% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Merck | 42 | Q3 2023 | 5.7% |
| Newmont Mining | 42 | Q3 2023 | 7.2% |
| Procter & Gamble | 42 | Q3 2023 | 4.9% |
| Intel | 42 | Q3 2023 | 5.0% |
| Johnson & Johnson | 42 | Q3 2023 | 3.7% |
| International Flavors & Fragra | 42 | Q3 2023 | 4.2% |
| Automatic Data Processing | 42 | Q3 2023 | 3.9% |
| Sysco | 42 | Q3 2023 | 4.2% |
| Northern Trust | 42 | Q3 2023 | 4.0% |
| Novartis AG (ADR) | 42 | Q3 2023 | 3.7% |
View WILKINS INVESTMENT COUNSEL INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-07 |
| 13F-HR | 2023-05-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-08 |
| 13F-HR | 2022-05-10 |
| 13F-HR | 2022-02-10 |
| 13F-HR | 2021-11-09 |
View WILKINS INVESTMENT COUNSEL INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.